Lipocine Inc.
Oral testosterone tridecanoate therapy
Last updated:
Abstract:
The present disclosure provides methods and compositions for testosterone replacement therapy. The methods and compositions employ a fixed dose dosing regimen that does not require titration or dose adjustments and that can provide a therapeutically effective amount of a testosterone ester while avoiding unacceptably high testosterone levels.
Status:
Grant
Type:
Utility
Filling date:
26 Dec 2019
Issue date:
5 Jan 2021